Product
|
Ref./storage
|
Indications (Posology)
|
Time
between injection and examination
|
Radiochemical
purity
|
Stability
labelled product
|
COLLOID
(Sulfur)
|
HEAPTOCIS (TCK-1) *12
months / RT
|
1.
Hepatic scintigraphy :
37~111 MBq/70 kg (1~3 mCi) 2.
Splenic scintigraphy :
74~111 MBq/70 kg (2~3 mCi) 3.
Bone marrow scintigraphy :
155 MBq/70 kg (4.2 mCi)
|
1.
Liver scanning : 20 min 2. Spleen scaning : 20 min 3.
Bone marrow scanning : 1h
|
¡Ã95%
|
6h
./ RT
|
HSA (Human
serum Albumin)
|
VASCULOCIS (TCK-2) *12
months/2~8°C
|
1.
Static blood pool imaging :
111~185 MBq (3~5 mCi) 2.
Angiography :
370~740 MBq (10~20 mCi) 3.
Blood flow studies :
18.5~185 MBq (0.5~5 mCi) 4.
Ventriculography :
185~925 MBq (5~25 mCi)
|
Shortly
|
¡Ã95%
|
8h
./ RT
|
HAM (Human
albumin microspheres)
|
MICROCIS (TCK-5) *18
months/2~8°C
|
1.
Pulmonary perfusion scintigraphy 2.
Venoscintigraphy :
37~185 MBq/70kg (1~5 mCi)
|
Immediately
|
¡Ã95%
|
6h
./ RT
|
DTPA (Diethylenetriaminepentaacetic
acid)
|
PENTACIS (TCK-6) *12
months/2~8°C
|
1.
Intravenous use Renal
scintigraphy -
plasma : 1.8~3.7 MBq (0.05~0.1mCi) -
scanning : 37~370MBq (1~10mCi) Brain
scanning :
185~740 MBq (5~20mCi) 2.
Inhalation nebuliser
: 50~1000MBq (13.5~27mCi) Lung
: 50~100MBq (1.35~2.7mCi) 3.
Gastro-oesophageal : 10~20MBq (0.3~0.54mCi)
|
Brain
static scanning : 1h tp several hours Renal sequent
: immediately Optimal static imaging : 1h
|
¡Ã95%
|
6h/2~8°C
|
HAA (Macroaggregated
albumin)
|
PULMOCIS *24
months/2~8°C
|
1.
Pulmonary perfusion scintigraphy :
37~185MBq (1~5mCi) 2.
Venoscintigraphy :
37~185MBq (1~5mCi)
|
Immediately
|
¡Ã95%
|
8h/2~8°C
|
PYP (Phyrophosphate) =
used for in vitro labelling of red blood cell with 99mTc
|
HEMATOCIS (TCK-11) *5
months / 2~8°C
|
1.
Blood pool scintigraphy :
890 MBq (740 to 925MBq) 24 mCi (20~25mCi) 2.
Blood volumn :
3MBq (1 to 5 MBq) 81 uCi (27 to 135 uCi) 3.
Spleen scintigraphy :
50MBq (20 to 70 MBq) 1.4 mCi (0.54 to 1.90 mCi)
|
Immediately
after administration of the 99mTc for
spleen scintigraphy
|
labelling
yield ¡Ã95%
|
3h
after labelling
|
DMSA (Dimercaptosuccinic
acid)
|
RENOCIS (TCK-12) *12
months/2~8°C
|
Static
(fubctional) renal scintigraphy :
30~120 MBq (0.8~3.2 mCi)
|
1.
Image acquisition L 1~3h 2.
Renal impairment : 6h 3.
Renal obstruction : 24h
|
¡Ã95%
|
6h
./ RT
|
PHYTATE
|
PHYTACIS (TCK-18) *6
months/2~8°C
|
Hepatic
scintigraphy :
37~100 MBq (1~2.7 mCi)
|
10~60
min
|
¡Ã95%
|
8h/2~8°C
|
DISIDA (Diisopropy
liminodiacetic acid)
|
CHOLECIS (TCK-22) *12
months/2~8°C
|
Hepatobilary
imaging Hepatobilary
function studies :
150~300 MBq (4.1~8.1 mCi)
|
1.
Patients fasting :
6h prior examination 2.
Biliary visualisation :
5~20 min after injection 3.
Gall bladder : 10~40 min
|
¡Ã95%
|
4h/RT
|
DPD (Diphosphono Propanedicarboxylic
acid)
|
TECEOS (DPD)
|
Bone
scintigraphy :
500 MBq (13.5mCi) or 300~700 MBq (8~19mCi)
|
Late
phase static scintigraphy should be performed not earlier
than 2 hours
|
¡Ã95%
|
8h/RT
|